Article
NCBoost v2: a classifier for non-coding single-nucleotide variants in Mendelian diseases.
Bioinformatics (Oxford, England) - 3 May 2026
Caron Barthélémy, Rausell Antonio
Abstract excerpt
MOTIVATION: The current diagnostic rate of rare diseases through whole-genome sequencing has stabilized at around 30% on average, highlighting the need for improved computational scores to identify pathogenic variants. In 2019, we developed NCBoost, a supervised-learning approach that mined a comprehensive set of sequence constraint features and proved particularly well suited to identifying high-effect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
